Activation of the ErbB2 receptor tyrosine kinase stimulates breast cancer cell migration. Cell migration is a complex process that requires the synchronized reorganization of numerous subcellular structures including cell-to-matrix adhesions, the actin cytoskeleton and microtubules. How the multiple signaling pathways triggered by ErbB2 coordinate, in time and space, the various processes involved in cell motility, is poorly defined. We investigated the mechanism whereby ErbB2 controls microtubules and chemotaxis. We report that activation of ErbB2 increased both cell velocity and directed migration. Impairment of the Cdc42 and RhoA GTPases, but not of Rac1, prevented the chemotactic response. RhoA is a key component of the Memo/ACF7 pathway whereby ErbB2 controls microtubule capture at the leading edge. Upon Memo or ACF7 depletion, microtubules failed to reach the leading edge and cells lost their ability to follow the chemotactic gradient. Constitutive ACF7 targeting to the membrane in Memo-depleted cells reestablished directed migration. ErbB2-mediated activation of phospholipase C gamma (PLCc) also contributed to cell guidance. We further showed that PLCc signaling, via classical protein kinases C, and Memo signaling converged towards a single pathway controlling the microtubule capture complex. Finally, inhibiting the PI3K/Akt pathway did not affect microtubule capture, but disturbed microtubule stability, which also resulted in defective chemotaxis. PI3K/Akt-dependent stabilization of microtubules involved repression of GSK3 activity on the one hand and inhibition of the microtubule destabilizing protein, Stathmin, on the other hand. Thus, ErbB2 triggers distinct and complementary pathways that tightly coordinate microtubule capture and microtubule stability to control chemotaxis. 
Introduction
Aberrant activation of receptor tyrosine kinases contribute to tumor development in various cancers including colorectal, lung, head and neck, brain and breast. Overexpression of the ErbB2/ Her2/Neu receptor is observed in 20 to 25% of breast cancer patients and is associated with a poor prognosis [1] . While the role of ErbB2 in tumor cell proliferation and survival has been largely studied, less is known about the possible contribution of ErbB2 to tumor cell motility, invasion and metastasis [2] .
ErbB2 is part of the ErbB family of receptor tyrosine kinase which includes ErbB1/Her1/EGFR (epidermal growth factor receptor), ErbB3 and ErbB4 [3] . ErbB2 has no known ligand. However, ligand binding to other ErbB family members triggers formation of receptor homodimers and ErbB2-containing heterodimers. In fact, ErbB2 containing dimers were found to be the most effective in term of signaling and transformation ability [4, 5] . Receptor dimerization leads to kinase activation and phosphorylation of specific tyrosine residues within the receptor C-terminal tail. Phosphorylated tyrosines serve as docking sites for PTB or SH2 domain containing proteins which initiate a variety of signaling pathways including the Ras/MAPK, Akt/PI3K, p38MAPK, JNK, STAT and Src-dependent pathways [6] . While many signaling pathways have been involved in cell motility, we observed little redundancy among major ErbB2-induced signaling pathways, indicating that each pathway carries a unique function [7] .
Cell motility is a complex process which integrates numerous discrete subcellular events that must be coordinated in space and time [8] . Schematically, in response to a ligand, cells polarize in the direction of the stimulus and undergo morphogenetic changes. The formation of a dense actin network underneath the plasma membrane causes membrane protrusion. Assembly and maturation of adhesion complexes organized around integrins allow cell attachment to the extracellular matrix. Contraction of the actomyosin stress fibers, which are anchored at adhesion sites, favors the detachment of the rear end and progression of the cell body. These processes are under the control of RhoGTPases. Cell motility is also accompanied by the assembly, at microtubule organizing centers (MTOCs), of microtubules whose dynamic plus-ends explore protrusions until reaching stabilizing structures at the cell periphery. Nonetheless, the function of microtubules during cell motility is still debated [9] .
We have previously identified a signaling pathway whereby ErbB2 controls microtubule capture at the cell leading edge. This pathway involves the recruitment of RhoA to the plasma membrane via the Memo adaptor and the activation of its effector, mDia1/DRF1 [7, 10] . In turn, activation of mDia1 results in repression of GSK3 activity, allowing localization of APC and ACF7 to the cell membrane and ACF7-dependent microtubule capture [11] . However, it is not clear how the numerous intracellular pathways triggered by ErbB2 receptor activation are coordinated to control microtubule outgrowth and stabilization in cell protrusions and how they might influence directed cell migration.
In this study we characterized the signaling network downstream of ErbB2 that underlies microtubule capture and stabilization in cell protrusions and its contribution to the cell chemotactic response.
Results

ErbB2-dependent chemotaxis
In order to determine the contribution of ErbB2-induced signaling to the discrete events required for cell motility, we have set up an ErbB2-dependent chemotactic migration assay in Dunn chambers. Motility of the T47D and SKBr3 breast carcinoma cell lines was evaluated by tracking individual cells as they migrated between two chambers in response to heregulin b1 (HRG; Fig. 1A ). It was shown previously that HRG-induced motility was strictly dependent on ErbB2 [7, 12] . Addition of equal concentrations of HRG in both chambers increased T47D (Fig. 1B) and SKBr3 (data not shown) cell speed and persistence. When exposed to a gradient of HRG, cell speed was further increased (Fig. 1B) and a large majority of cell migrated towards the source of HRG (Fig. 1A) ; this was also clearly visible in Rose plots (Fig. 1C ) that reflected cell distribution independently of the distance traveled. The Rayleigh statistical test confirmed that, in the absence of ligand or in the presence of homogenous concentrations of HRG, cells showed random migration (p.0.05), while in the presence of the HRG gradient, migration was very strongly biased towards the areas of highest HRG concentrations.
Role of the Memo/RhoA/ACF7 pathway in ErbB2-dependent chemotaxis RhoGTPases are amongst the main regulators of cell migration. In order to evaluate the contribution of RhoGTPases to ErbB2-dependent chemotaxis, cells were transfected with dominant negative (DN) Rho constructs, before being exposed to the HRG gradient. Inhibition of Rac1 activity led to disturbed cell protrusion (data not shown) and to a significant decrease in cell speed ( Fig. 2A) , as expected from the role Rac1 plays in cortical actin formation. Interestingly, even though cell velocity was considerably reduced, cells were still capable of gradient sensing and chemotactic migration (Fig. 2B) . Cdc42 was previously involved in both actin nucleation and cell polarity. Inhibition of Cdc42 activity did not significantly affect cell speed ( Fig. 2A) , but prevented oriented migration (Fig. 2B) . DN-RhoA significantly affected cell speed in accordance with RhoA function in cell contractility ( Fig. 2A) . Unexpectedly, inhibition of RhoA activity also led to a complete loss of chemotaxis (Fig. 2B) .
We have previously identified a signaling pathway whereby ErbB2 controls microtubule capture at the cell leading edge, which involved recruitment of RhoA to the plasma membrane via the Memo adaptor, repression of GSK3 activity and re-localization of ACF7 to the cell membrane, via APC [10, 11] . Similarly, in the chemotaxis setting RhoA was recruited to cortical areas and colocalized with its effectors, mDia1 and APC (data not shown). Therefore, we have investigated whether the loss of oriented migration observed upon inhibition of RhoA activity was linked to disturbance of the Memo/ACF7 pathway. SiRNA-mediated depletion of Memo or ACF7 (supplementary material Fig.  S1A ,B) or expression of a constitutively active form of GSK3 strongly disturbed the chemotactic response, leading to random cell motility (Fig. 2C) . Loss of chemotaxis paralleled defective capture of microtubule at the cell leading edge (Fig. 2C) . We have previously shown that expression of an ACF7 mini-gene composed of ACF7 N-terminal and C-terminal sequences, rescued microtubule capture in Memo knockdown cells only when fused to the CCKVL membrane targeting sequence [11] . We confirmed that expression of ACF7-CCKVL restored peripheral microtubules; but we also showed that it was sufficient to reestablish oriented migration in both T47D (Fig. 2C ) and SKBr3 (data not shown) Memo-depleted cells. Thus, our data show that the Memo/ACF7 pathway is required for ErbB2-induced chemotactic migration and link microtubule capture at the cell front to oriented migration.
Characterization of the PLCc pathway involved in ErbB2-dependent chemotaxis
Activated ErbB2 triggers multiple pathways that are involved in cell motility. Previous data has shown that PLCc was involved in microtubule outgrowth and cell motility [7, 13] . However, the mechanism whereby PLCc controlled microtubule capture was not explored.
Using siRNAs (supplementary material Fig. S1C ), we confirmed that depletion of PLCc had a significant impact on cell velocity (Fig. 3A) , chemotactic migration ( Fig. 3B ) and microtubule capture ( Fig. 3D; supplementary material Fig. S2 ). We next investigated if the PLCc and Memo/ACF7 signaling pathways interacted. Similarly to what was observed in Memo-depleted cells, expression of membrane-targeted ACF7 restored microtubule capture in both SKBr3 ( Fig. 3D ; supplementary material Fig. S2 ) and T47D (data not shown) PLCc-depleted cells, while expression of ACF7 was not efficient. These results suggested that, similarly to Memo, PLCc controlled microtubule capture via the recruitment of ACF7 to the leading edge. To determine at what level the two pathways converged, we expressed components of the Memo signaling cascade in either Memo-or PLCc-depleted cells (Fig. 3C) : overexpression of constitutively active mDia1 or of DN-GSK3 restored functionality of the Memo pathway in Memo-knockdown cells ( Fig. 3D and supplementary material Fig. S2 ). In contrast, while DN-GSK3 restored microtubule capture, expression of active mDia1 did not restore microtubules in PLCc-knockdown cells ( Fig. 3D and supplementary material Fig. S2 ), indicating that PLCc impacted the Memo pathway downstream of mDia1. Moreover, we found that PLCc was required for ErbB2-induced relocalization to the leading edge of phosphorylated GSK3 and APC, but not of mDia1 (supplementary material Fig. S3 ). Altogether, these results strongly suggest that the PLCc pathway converges towards the Memo/ACF7 pathway, downstream of mDia1 and upstream of GSK3.
Role of Protein Kinases C (PKCs) in ErbB2-induced microtubule capture
PLCc is known to catalyze the hydrolysis of membrane phosphatidylinositol 4,5-bisphosphate into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate, which in turn leads to the release of intracellular Ca 2+ . As a consequence PLCc activation leads to the activation of various PKCs. The PKC family can be divided in distinct subgroups according to their regulatory domains: the conventional PKCs (cPKCs) are activated by a combination of DAG and Ca 2+ -dependent phospholipid binding; novel PKCs (nPKCs) are activated by DAG and phospholipids, but do not directly respond to Ca 2+ ; the atypical PKCs (aPKCs) do not generally respond to Ca 2+ or DAG [14] . We have evaluated which PKCs were involved in ErbB2-dependent microtubule capture, by expressing DN PKC constructs representative of the various PKC subgroups into SKBr3 cells (supplementary material Fig. S4A ). Disturbing the activity of PKCa, PKCb, PKCc (cPKCs), PKCd (an nPKC) or PKCf (an aPKC) led to abnormal peripheral microtubules, while DN constructs for the PKCe and g (nPKCs) had no effect (supplementary material Fig. S4B ). Interestingly, when individual cPKCs or PKCd were inhibited, microtubules were disturbed but showed a phenotype distinct from the one seen upon inhibition of Memo or PLCc (Fig. 4A,B) . Memo depletion typically induced microtubules that failed to extend within cell protrusions and remained at the basis of the lamella, with microtubule ends running parallel to the cell membrane; upon inhibition of individual cPKCs, microtubules were capable of extending within the lamella, pointed perpendicularly to the cell front, but remained at a short distance from the leading edge. Inhibition of PKCf led to the typical arrest of microtubules at the basis of the lamella (Fig. 4A,B) .
To confirm the data obtained with the DN PKC constructs, we have used inhibitory peptides (pseudosubstrates) specific of cPKCs, PKCg or PKCf. Similarly, to what we observed with DN constructs, peptide-mediated inhibition of cPKCs or PKCf activity prevented microtubule capture (Fig. 4A,B) , while PKCg inhibitory peptide had no effect (data not shown). However, cPKC inhibitory peptide had a more drastic effect that inhibition of individual cPKCs via DN constructs, yielding microtubules arrested at the basis of the lamella.
We have postulated that defects in microtubule capture correlated with loss of the chemotactic response. Thus, we have investigated the consequence of PKC inhibition on oriented migration. Inhibition of cPKCs or PKCf activity that led to lamella-arrested microtubules, also resulted in disturbed cell chemotaxis (Fig. 4C ). Interestingly, cells in which PKCa activity was inhibited via the DN construct, that showed microtubules stabilized at a short distance from the leading edge, were still capable of oriented migration (Fig. 4C) .
Finally, we explored the link between PKCs and ACF7-mediated microtubule capture. Expression of the membranetargeted ACF7 (ACF7-CCKVL) or of APC (which allows the recruitment of ACF7 to the membrane [11] ) restored the capture of microtubules in cells in which cPKC activity was inhibited ( ACF7 to the plasma membrane, whereas PKCf acts via a more complex mechanism.
Thus, both PLCc and cPKCs mediates ErbB2-induced microtubule capture via an ACF7-dependent pathway. In order to demonstrate that cPKCs are actual effectors of PLCc, we evaluated if a constitutively active, myristoylated, form of PKCa is able to compensate the loss of PLCc. We observed that active PKCa restored extension of microtubules within cell protrusions ( leading edge (Fig. 5B and supplementary material Fig. S5B ). Thus, both PKCa and PKCf act downstream of PLCc for ErbB2-dependent capture of microtubules, but operate via distinct mechanisms.
The PI3K pathway controls microtubule stability and chemotaxis
Our results showed the involvement of the Memo and PLCc pathways in ErbB2-dependent microtubule capture and chemotactic migration. Next, we investigated the contribution of canonical pathways to ErbB2-dependent chemotaxis. Using small molecule inhibitors, we have inhibited the Ras/MAPK, the p38MAPK and the PI3K/Akt pathways in SKBr3 cells. Surprisingly, disturbance of any of these pathways prevented oriented migration (supplementary material Fig. S7A ). However, in contrast to what we observed previously, loss of chemotaxis was not associated with defective microtubule capture (supplementary material Fig. S7B ). In fact, closer examination of the effect of the PI3K inhibitor, LY294004, showed that microtubules were initially captured at the leading edge, but progressively disassembled, starting from the cell periphery ( Fig. 6A ; supplementary material Movie 1). Ninety minutes after HRG treatment, most cells were virtually devoid of polymerized microtubules (Fig. 6B) . Similar microtubule disassembly was induced by Akt inhibitor VIII (Fig. 6B) , confirming that the effect was due to inhibition of the PI3K/Akt pathway. Biochemical analysis confirmed the loss of microtubules and the increase in soluble tubulin upon inhibition of PI3K (Fig. 6C) or Akt (data not shown). In contrast inhibition of the Ras/MAPK or the p38MAPK pathway had little or no impact on microtubule assembly (supplementary material Fig. S7C ). Similar results were observed in T47D cells.
Our data suggest that microtubules play a critical role in oriented migration. If this assumption is correct, the inhibition of PI3K, which induced slow and progressive microtubule disassembly, should have a gradual impact on chemotaxis as well. We actually observed that at early time points, when microtubules were intact, cell migrated in an oriented manner, whereas at later time points, when microtubules were disassembled, cells lost the ability to follow the gradient, as confirmed by the Rayleigh test ( Fig. 6A and video 1) . This gradual disturbance of chemotactic behavior was specifically associated with inhibition of the PI3K pathway, as inhibition of Memo or PLCc led to an immediate and persistent loss of oriented migration (data not shown).
Mechanisms of PI3K-mediated microtubule stability
We have then investigated the signaling pathway by which the PI3K/Akt pathway regulates microtubule stability. GSK3 is a major substrate of Akt. GSK3 is a constitutively active kinase in resting cells and phosphorylation of GSK3b/a on Ser9/21 reduces GSK3 activity. Moreover, GSK3 activity has been associated with microtubule stability during neuron axonal growth [15] . We have thus investigated the possible contribution of GSK3 to PI3K-dependent microtubule stability. We found that inhibition of GSK3, via addition of LiCl or via a dominant negative construct (data not shown), prevented microtubule disassembly induced by inhibition of PI3K/Akt (Fig. 7A,D) and restored oriented migration (Fig. 7B) . Our data imply that ErbB2 induces stabilization of microtubules via PI3K/Akt-dependent repression of GSK3 activity.
Microtubule stability is dependent on the balance between stabilizing and destabilizing microtubule-associated proteins (MAPs). We have investigated the implication of Stathmin, a major destabilizing MAP, in ErbB2-dependent microtubule stability. Activation of ErbB2 induced phosphorylation of Stathmin, as seen by the use of an antibody directed against phosphorylated Ser16, one of the main phosphorylation sites of Stathmin (Fig. 7C) . Inhibition of PI3K activity strongly decreased ErbB2-induced phosphorylation of Stathmin in both SKBr3 (Fig. 7C ) and T47D cells (data not shown). Phosphorylation of Stathmin was previously demonstrated to result in functional inactivation, by decreasing the ability of Stathmin to associate with microtubules [16] . Thus, inhibition of PI3K/Akt could prevent Stathmin inactivation, resulting in Stathmin-mediated microtubule destabilization. We evaluated this hypothesis by depleting Stathmin with siRNAs, before inhibiting the PI3K/Akt pathway. We observed that depletion of Stathmin prevented microtubule destabilization induced by inhibition of PI3K or Akt (Fig. 7A,D) and restored chemotaxis (Fig. 7B) , showing that Stathmin is a critical component of the ErbB2/PI3K/Akt pathway that controls microtubule stability. Since inhibition of GSK3 also restored microtubules in PI3K/Akt inhibited cells, we investigated GSK3 acted via the regulation of Stathmin phosphorylation. Concomitant inhibition of PI3K and GSK3 activity did not restore phosphorylation of Stathmin (Fig. 7C) showing that GSK3 does not act via the regulation of Stathmin and suggesting that GSK3 and Stathmin belong to parallel pathways.
Since GSK3 did not regulate the phosphorylation of Stathmin, we investigated other potential regulators of Stathmin. The PAK kinases were good candidates, as they were previously suggested to directly control the phosphorylation of Stathmin downstream of the EGFR [17] . Activation of ErbB2 led to phosphorylation of PAK1/2 (Fig. 7E) . Interestingly, PAK phosphorylation was partially reduced by inhibition of Rac1 or Cdc42, but was strongly diminished by inhibition of Akt (Fig. 7E ). In addition, we found that inhibiting PAK1 activity, using DN-PAK1 construct or a chemical inhibitor, led to decreased HRG-induced Stathmin phosphorylation (Fig. 7F) , suggesting that PI3K/Akt function via PAK-mediated phosphorylation of Stathmin. Thus, the microtubule destabilizing effect of PI3K inhibitors appears to be mediated by the activation of GSK3 on the one hand and the inhibition of PAK1 on the other hand. However, expression of an active form of GSK3 did not result in microtubule disassembly, but induced defective microtubule capture (Fig. 7G) . Similarly expression of DN-PAK1 resulted in non-captured microtubules. Interestingly, concomitant expression of active GSK3 and DN-PAK1 significantly increased microtubule disassembly (Fig. 7G) , mimicking inhibition of PI3K/Akt. Thus, our data suggest that ErbB2-induced activation of PI3K/ Akt leads to activation of PAK1 and phosphorylation of Stathmin on the one hand and inhibition of GSK3 activity on the other hand, to support microtubule stability and chemotaxis. 
Discussion
Receptor tyrosine kinases stimulate cell migration via numerous intracellular pathways, including kinase-and GTPase-dependent signaling cascades. It is important to understand how these multiple pathways coordinate in time and space the discrete subcellular processes that underlie cell motility and in particular microtubule dynamics. Microtubules can regulate cell motility in different ways: they contribute to cell asymmetry and the delivery of cargos to the cell front, they control the assembly of the actin cytoskeleton and modulate adhesion site turnover [18] . We have determined how ErbB2-induced signaling pathways are coordinated to control microtubule stabilization at the leading edge. We found that the Memo and the PLCc-dependent pathways act together to control microtubule capture at the cell front during the early steps of motility, whereas the PI3K/Akt pathway stabilizes microtubules at later times, via the control of Stathmin phosphorylation and GSK3 activity (Fig. 8) . Moreover, we observed that microtubule capture and stabilization within cell protrusions determine the ability to migrate along the chemotactic gradient.
PLCc was shown to control cell chemotactic migration downstream of ErbB2 [7, 13] . We found that the PLCc and Memo pathways converged toward a single pathway that controlled ACF7 association to the cell leading edge. Our data showed that PLCc-dependent microtubule capture required the activity of conventional PKCs. PKCs have been involved in microtubule stabilization downstream of mDia2 during woundhealing dependent fibroblast migration [19] , even though the study identified nPKCs and excluded conventional cPKCs, as important actors for controlling microtubule stability. Moreover, mDia2/nPKC did not contribute to MTOC reorientation -which was dependent on a distinct Cdc42 signaling complex. In contrast, the Memo/PLCc/cPKC pathway controlled both microtubule capture at the cell leading edge and cell orientation, in response to HRG.
Interestingly we observed that interfering with individual cPKCs yielded cells with microtubules arrested within the lamella, at a short distance of the leading edge. These cells were capable of chemotactic migration in response to the HRG gradient, suggesting that these microtubules were anchored at a yet undefined structure. A previous study suggested that microtubules were connected to actin filaments, via ACF7, in the vicinity of adhesion sites [20] . More recently it was shown that, in astrocytes, microtubules came in closest contact to the basal plasma membrane at ,5 mm behind the leading edge, in a region distinct from the actin-rich adhesive zone, thanks to dynein-generated forces [21] . Further investigation should determine if, upon cPKC disturbance, microtubules anchor at the basal plasma membrane, at or behind adhesion-enriched sites, and by what mechanism.
In our work, PKCf was also found to contribute to microtubule capture downstream of PLCc, which could appear surprising as aPKC activation is not dependent on Ca ++ or DAG. However, a recent study showed that DAG conversion into phosphatidic acid, by diacylglycerol kinase a, can provide a signal for recruitment and activation of aPKCs [22] . Interestingly, PKCf appeared to contribute to the recruitment of Memo and all downstream effectors; moreover, our data also showed that, in contrast to cPKCs, aPKCs did not act solely via the recruitment of ACF7. It will therefore be important to investigate the complex mechanism by which aPKCs contribute to microtubule capture.
Previous studies suggested that establishment of polarity and centrosome repositioning were determined by the Par6/aPKC complex, downstream of Cdc42, via repression of GSK3 activity [23, 24, 25] . Interestingly, in our cellular model, invalidation of aPKCs affected cell orientation along the gradient, without preventing antero-posterior cell polarity, underscoring the fact that the control of cell polarity and the control of cell orientation during motility depend on distinct mechanisms. Thus, aPKCs might stand at the crossroads of pathways directing cell orientation, downstream of PLCc and cell polarity, downstream of Cdc42.
Cdc42 itself plays a dual role in chemotaxis. Indeed, expression of DN-Cdc42 disturbed cell orientation without disturbing frontrear polarity. However, we observed that when it is expressed at very high levels, DN-Cdc42 induced cell rounding (KB and AB, unpublished data). This observation suggests that low Cdc42 activity might be sufficient to allow cell polarization, and that higher levels of Cdc42 activity are required for cell orientation. This latter function could involve the control of MTOC reorientation via the recruitment of the minus-end directed dynein motor at cortical sites and generation of pulling forces on microtubules [21, 26, 27] .
Memo and PLCc control the recruitment to the leading edge of cofilin [13] , a protein involved in early chemotaxis events, such as Figure 8 . Model of the ErbB2 signaling network that controls microtubule capture, microtubules stability and chemotaxis. Our data show that ErbB2 controls microtubules via distinct, but complementary, signaling pathways. The Memo/RhoA and the PLCc/ cPKC pathways converge to control ACF7 localization at the leading edge, allowing microtubule capture. While PKCf is also required downstream of PLCc, its mode of action is still unknown. The PI3K/ Akt pathway contributes to microtubule stability, at later stages, and involves the combined effect of the PAK/Stathmin pathway and repression of GSK3 activity. Microtubule capture and stabilization allow the chemotactic response to HRG. doi:10.1371/journal.pone.0055211.g008 localized actin assembly and protrusion [28, 29] . Interestingly, a recent study suggested that in neutrophils, PLCb/PKC controlled GSK3 phosphorylation and as a consequence cofilin phosphorylation and chemotaxis [30] . We do not know whether this pathway is functional in epithelial cells; but it is tempting to speculate that the PLC/PKC/GSK3 axis might coordinate both actin cytoskeleton reorganization and microtubule capture during chemotaxis.
Our results show that the PI3K/Akt is required to maintain a stable microtubule network during migration. In the absence of PI3K or Akt activities, captured microtubules progressively disassembled and cells lost the ability to follow the chemotactic gradient. Our data show that PI3K functions via the control of Stathmin activity. Several kinases are able to directly phosphorylate Stathmin [31] . Among the few that phosphorylate Stathmin on Ser16, PAK1 was a good candidate, because of its described links with ErbB2 [32, 33] . We confirmed that ErbB2-induced phosphorylation of Stathmin was dependent on PAK activity, which in turn was dependent on PI3K activity. Other reports have involved PI3K signaling in the activation of PAK: Akt phosphorylation of Ser21 and PDK phosphorylation of threonine 423 were found to contribute to PAK activation [34, 35] . But the physiological relevance of these observations has been questioned. We show here that PI3K-dependent activation of PAK has a critical function for the control of Stathmin phosphorylation and microtubule stabilization. It will be interesting to determine how Rac1, Cdc42 and PI3K signals are integrated to regulate ErbB2-induced activation of PAK. We observed a delay between the (early) inhibition of Stathmin phosphorylation by PI3K/Akt and the (late) disassembly of microtubules, suggesting that microtubules might be transiently protected from disassembly by capping proteins or MAPs.
GSK3, a well-known target of Akt, also contributed to microtubule stability, downstream of PI3K. GSK3 activity, however, did not affect Stathmin phosphorylation, showing that PI3K initiated at least two distinct pathways that contributed to microtubule stability. GSK3 might act via the regulation of stabilizing MAPs, as demonstrated in neurons [36, 37] . We do not know what MAPs might be involved downstream of GSK3 in our experimental model, but MAP4 and Stathmin were suggested to have interphase-specific, counteractive and phosphorylation-inactivated activities in many mammalian cell types [38] .
Collectively our results underline that distinct and complementary ErbB2-dependent signaling pathways coordinately control microtubule capture and microtubule stability to allow chemotactic migration. Kinases such as GSK3 or PAK1 appear pivotal for these functions. The fact that the same switch kinases are also central for processes such as cell-to-matrix adhesion and actin assembly/disassembly illustrates how signaling pathways controlling different aspects of cell motility are intermingled. Such signaling nodes, which integrate various signaling to coordinate an array of discrete processes, constitute attractive therapeutic targets in the context of migration-related pathologies.
Materials and Methods
Cell culture and transfection
Analysis of microtubules status and immunofluorescence
For microtubules status analysis, cells transfected with EGFPtubulin were grown on collagen-coated glass coverslips for 48 h and observed upon addition of 5 nM HRGb1 using the 636 objective (plan apochromat NA 1.4) of a fluorescence microscope (Zeiss Axiovert 200) driven by Metamorph 6.3 software. Images were acquired using a digital camera (Coolsnap HQ; Roper Scientific). At least 200 cells were counted for each condition in three independent experiments. For immunofluorescence, cells grown on collagen-coated coverslips were fixed in 4% paraformaldehyde and permeabilized in 0.2% Triton-X-100 before addition of antibodies directed toward mDia1/DRF1 (Santa Cruz Biotechnology), APC C terminus (Santa Cruz Biotechnology, Heidelberg, Germany) and phospho-GSK3b (Cell Signaling Technology). Alexa secondary antibodies were from Life technologies. When required, signal was amplified using a biotinylated secondary antibody and streptavidin-FITC (BD Biosciences, Le Pont de Claix, France). DNA was counterstained with Hoechst dye (Sigma-Aldrich). Images were recorded with a confocal Imager (Z1 Zeiss microscope), 1006 plan objective (1.4 NA) coupled to an AxioCam MRm camera, driven by LSM software. The percentage of cells displaying cortical labeling was quantified. More than 300 cells were counted for each condition in three independent experiments. Results were analyzed with GraphPad Prism. Means and SEM are shown.
Chemotaxis assay
Chemotaxis was measured by direct observation and recording of cell behavior in a stable HRGb1 gradient using Dunn chemotaxis chambers (Hawksley Technology, Lancing, UK) as described [39, 40] . Cells were grown on collagen-coated glass coverslips for 48 hours before setting up the chemotaxis chambers.
Gradients of HRGb1 were formed by placing HRGb1-containing (10 and 40 nM for SKBr3 and T47D cells respectively) DMEM/ 10% FCS in the outside well and HRGb1-free DMEM/10% FCS in the inside well. For no gradient controls, DMEM/10% FCS with 5 and 10 nM HRGb1 for SKBr3 and T47D cells was placed in both the inside and outside wells. Images were acquired using the 106 plan apochromat (NA 1.4) objective of a Zeiss Axiovert 200 microscope with a time interval of 8 minutes for 8 and 4 hours for SKBr3 and T47D cells, respectively, using a digital camera (Coolsnap HQ; Roper Scientific) driven by Metamorph 6.3 software. 90 to 150 cells were tracked for each condition in three independent experiments using Metamorph 6.3 software. Tracks were analyzed using the Chemotaxis and Migration Tool (Image J) to obtain cell speed and persistence (ratio of total distance travel to Euclidian distance). Statistical analysis was performed with GraphPad Prism. Means and SEM are shown. Cell orientation was shown as Rose plots. The Rayleigh test for unimodal clustering of directions was used to test if the cell population displayed directionality in the chemotactic gradient [39] . Distribution of directions was considered uniform (random migration) for p.0.05.
Western Blotting
Cells were collected in lysis buffer as described [10] . Western blotting was performed using antibodies directed against Memo (monoclonal antibody to amino acids 25-43), PLCc1, GSK3b, phospho-GSK3b (Ser9), phospho-PAK (Cell Signaling Technology, Danvers, MA, USA), mDia1, Cdc42, RhoGDIa, PAK, HA (Santa Cruz Biotechnology), a-tubulin, Stathmin (Sigma-Aldrich), Rac1 (BD Transduction Laboratories) and phospho-Stathmin (Ser16) (a kind gift from A. Sobel, Institut du Fer à Moulin, Paris).
Tubulin/microtubule fractions
Cells were grown for 48 h before treatment with the indicated drug for 1 h, and then stimulated with HRG b1. Cells were washed twice with warm phosphate buffer saline, before addition of warm OPT buffer (80 mM K-PIPES pH 6.8, 1 mM EGTA, 1 mM MgCl 2 , 0.5% Triton-X-100, 10% glycerol containing complete protease inhibitor cocktail from Roche and phosphatase inhibitors cocktails II and III from Sigma-Aldrich). The dish was stirred very gently by hand and the soluble fraction (containing ''soluble tubulin'') immediately recovered. Cells were washed once with warm OPT before scrapping in OPT buffer and freezing at 280uC. Samples were centrifuged at 10 000 g, before collecting the supernatant (''microtubule fraction''). Figure S1 Validation of Memo, ACF7 and PLCc1 siRNAs. SKBr3 cells were transfected with siRNAs or an ACF7-CCKVL construct, as indicated. Expression of the target protein was analyzed by Western Blotting (A and C). An antiRhoGDI antibody was used to assess comparable protein loading. Expression of ACF7 was analyzed by FACS (B) as described before (11) . A combination of both PLCc1 siRNAs was used in this study. 
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